These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19802801)

  • 21. [Hypoadiponectinemia: a cardiovascular risk factor in uremia. A view from the evidence].
    Estrada PN; Bajo MA; del Peso G; Iglesias P; Díez JJ; Fernández-Reyes MJ; Grande C; Sánchez Hernández R; Selgas R
    Nefrologia; 2006; 26(6):653-7. PubMed ID: 17227241
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cardiovascular calcification and accelerated atherosclerosis in chronic kidney disease].
    Cozzolino M; Butti A; Chiarelli G; Rocca-Rey L; Santagostino G; Gallieni M; Brancaccio D
    Ital Heart J Suppl; 2005 Jan; 6(1):25-8. PubMed ID: 15776728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular disease in uremic patients on hemodialysis.
    Lazarus JM; Lowrie EG; Hampers CL; Merrill JP
    Kidney Int Suppl; 1975 Jan; (2):167-75. PubMed ID: 1099301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-reactive protein and uremia.
    Wanner C; Drechsler C; Krane V
    Semin Dial; 2009; 22(4):438-41. PubMed ID: 19708997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular function in hemodialysis patients.
    London GM; Marchais SJ; Guerin AP; Fabiani F; Metivier F
    Adv Nephrol Necker Hosp; 1991; 20():249-73. PubMed ID: 2063715
    [No Abstract]   [Full Text] [Related]  

  • 26. Patients with vascular calcifications are at increased risk of cardiovascular events: implications for risk factor management and further research.
    Iribarren C
    J Intern Med; 2007 Mar; 261(3):235-7. PubMed ID: 17305645
    [No Abstract]   [Full Text] [Related]  

  • 27. [Vascular calcification mechanisms in uremia].
    Rodríguez M; Bas A
    Nefrologia; 2004; 24 Suppl 4():40-2. PubMed ID: 15279385
    [No Abstract]   [Full Text] [Related]  

  • 28. The pathogenesis of metastatic calcification in uraemia.
    Ibels LS
    Prog Biochem Pharmacol; 1980; 17():242-50. PubMed ID: 7208503
    [No Abstract]   [Full Text] [Related]  

  • 29. [Physical training in uremia: a healthy approach to cardiovascular risk].
    Fabbian F
    G Ital Nefrol; 2008; 25(1):7. PubMed ID: 18264908
    [No Abstract]   [Full Text] [Related]  

  • 30. The microinflammatory state of uremia.
    Schömig M; Eisenhardt A; Ritz E
    Blood Purif; 2000; 18(4):327-32. PubMed ID: 10965076
    [No Abstract]   [Full Text] [Related]  

  • 31. The cardiovascular burden of end-stage renal disease patients.
    Cianciolo G; Donati G; La Manna G; Ferri A; Cuna V; Ubaldi G; Corsini S; Lanci N; Colì L; Stefoni S
    Minerva Urol Nefrol; 2010 Mar; 62(1):51-66. PubMed ID: 20424570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular disease in the dialysis population: prognostic significance of arterial disorders.
    Guérin AP; Pannier B; Marchais SJ; London GM
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):105-10. PubMed ID: 16481874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular calcification and increased mortality in dialysis patients: Is the baroreflex sensitivity the answer?
    Zitt E; Rosenkranz AR
    Nephrol Dial Transplant; 2005 Nov; 20(11):2580. PubMed ID: 16091373
    [No Abstract]   [Full Text] [Related]  

  • 34. Vascular calcification: Hardening of the evidence.
    Moe SM
    Kidney Int; 2006 Nov; 70(9):1535-7. PubMed ID: 17051256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible association between circulating vascular endothelial growth factor and oxidative stress markers in hemodialysis patients.
    Pawlak K; Pawlak D; Myśliwiec M
    Med Sci Monit; 2006 Apr; 12(4):CR181-5. PubMed ID: 16572054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Risk factors and cardiovascular disease in uremic patients].
    Valdés F; Morales JM
    Nefrologia; 2002; 22 Suppl 4():1-6. PubMed ID: 12123136
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiovascular disease in uremic patients on hemodialysis.
    Lazarus JM; Lowrie EG; Hampers CL; Merrill JP
    R I Med J (1976); 1976 Feb; 59(2):57-64, 72-4. PubMed ID: 766139
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cardiovascular risk markers in hemodialysis].
    Urso S; Milone F; Garozzo M; Cannavò ME; Biondi A; Battaglia G
    G Ital Nefrol; 2004; 21 Suppl 30():S212-6. PubMed ID: 15750988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical images: Dialysis-associated uremic tumoral calcinosis.
    Oglesby R; Ceruti R; De Luigi J; Cueto P
    Arthritis Rheum; 2002 May; 46(5):1416. PubMed ID: 12115262
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hyperphosphatemia and cardiovascular risk in patients on dialysis].
    Basić-Jukić N; Kes P
    Acta Med Croatica; 2004; 58(3):207-13. PubMed ID: 15503684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.